Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEBRO: Eplerenone vs Irbesartan in Obese Hypertensive Patients
NCT03476616Phase 4Completed
- Sponsor
- Hippocration General Hospital
- Start
- Sep 2018
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of eplerenone in hypertension (HTN) (2 arms), sponsored by Hippocration General Hospital. Primary endpoint: Difference in change of Ambulatory Blood Pressure Measurement from baseline at 24 weeks. Started Sep 2018; status: completed.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03476616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476616.